Asston Pharmaceuticals (BOM:544445) Accounts Payable: ₹57.6 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:544445 Asston Pharmaceuticals Ltd BOM:544445
20 GF Score
Price ₹105.44
! 3 Warning Signs
View Full Analysis

What is Asston Pharmaceuticals Accounts Payable?

Asston Pharmaceuticals BOM:544445 +9.78% 20 Accounts Payable is ₹57.6 Mil as of Mar. 2026. GuruFocus rates BOM:544445 with a GF Score™ of 20/100. The stock has 3 warning signs investors should review.

Asston Pharmaceuticals's Accounts Payable for the quarter that ended in Mar. 2026 was ₹57.6 Mil.

Asston Pharmaceuticals's quarterly Accounts Payable declined from Mar. 2025 (₹58.6 Mil) to Sep. 2025 (₹50.3 Mil) but then increased from Sep. 2025 (₹50.3 Mil) to Mar. 2026 (₹57.6 Mil).

Asston Pharmaceuticals's annual Accounts Payable increased from Mar. 2024 (₹58.1 Mil) to Mar. 2025 (₹58.6 Mil) but then declined from Mar. 2025 (₹58.6 Mil) to Mar. 2026 (₹57.6 Mil).

Asston Pharmaceuticals Accounts Payable Related Terms

Asston Pharmaceuticals Accounts Payable Historical Data

* Premium members only.

The historical data trend for Asston Pharmaceuticals's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Asston Pharmaceuticals Accounts Payable Chart

Asston Pharmaceuticals Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Accounts Payable
45.30 55.40 58.10 58.62 57.58

Asston Pharmaceuticals Semi-Annual Data
Mar22 Mar23 Mar24 Sep24 Mar25 Sep25 Mar26
Accounts Payable Get a 7-Day Free Trial 58.10 0.00 58.62 50.32 57.58
BOM:544445
20GF Score
Asston Pharmaceuticals Ltd BOM:544445
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Asston Pharmaceuticals Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of ₹57.6 Mil mean?
Asston Pharmaceuticals (BOM:544445) has a Accounts Payable of ₹57.6 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Asston Pharmaceuticals and its competitors.
Is Asston Pharmaceuticals' Accounts Payable too high?
Asston Pharmaceuticals' current Accounts Payable is ₹57.6 Mil. Overall, Asston Pharmaceuticals has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Asston Pharmaceuticals' Accounts Payable compare to ZTS?
Asston Pharmaceuticals' Accounts Payable of ₹57.6 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Drug Manufacturers company?
A good Accounts Payable depends on the Drug Manufacturers industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Asston Pharmaceuticals and its competitors. Asston Pharmaceuticals's current Accounts Payable is ₹57.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asston Pharmaceuticals stock overvalued right now?
Asston Pharmaceuticals (BOM:544445) has a current Accounts Payable of ₹57.6 Mil. The current Accounts Payable is ₹57.6 Mil. Asston Pharmaceuticals' overall GF Score™ is 20/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Asston Pharmaceuticals (BOM:544445), the current Accounts Payable is ₹57.6 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Asston Pharmaceuticals Business Description

Address Plot No 42A, Sector-11, 4th Floor, Office No. A-431 Balaji Bhavan, CBD Belapur, Navi Mumbai, Thane, MH, IND, 400 614
Asston Pharmaceuticals Ltd manufactures and exports pharmaceutical and nutraceutical products. The company produces a wide range of healthcare items including tablets, capsules, syrups, sachets, ointments, creams, gels, and lotions. It serves markets in West and South Africa, with expansions planned into Asian countries. Asston conducts business through export sales, contract manufacturing and loan license arrangements via merchant exporters, and domestic sales within India. Revenue is generated through the sale of branded and generic pharmaceutical formulations along with nutraceutical products. The business operations are broadly categorized into: Domestic Formulations, Export Formulations, APIs and Intermediates, and Research and Development.
20GF Score

Get the complete analysis for BOM:544445

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹105.44
Price